Jump to content

Talk:Matthias Hentze/Archive 1

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia
Archive 1

Request edit on 12 June 2015


Dear all,

As recommended by Jytdog, I'm inserting my editing request here. I've gone through the whole article of Matthias Hentze and added references to the respective sections.

Please replace all content including section "Editorial Boards" as follows:

Matthias Werner Hentze, MD (born 25 January 1960 in Wiedenbrück, West Germany) is a German scientist. Currently, he is the Director of the European Molecular Biology Laboratory (EMBL)[1] and Professor of Molecular Medicine at Heidelberg University.[2]

Biography

Matthias Hentze studied medicine in the UK at the Medical Schools in Southampton, Oxford, Glasgow and Cambridge, and in Germany at the Westfälische Wilhelms-Universität Münster from which he qualified in 1984. In the same year, he received his M.D. degree for work on lysosomal enzyme biogenesis[3] in the laboratory of Prof. Kurt von Figura.[4] After a short phase of clinical work and supported by a fellowship awarded by the Deutsche Forschungsgemeinschaft (German Research Council),[5] Hentze became a postdoctoral fellow in Dr. Richard Klausner’s laboratory at the National Institutes of Health (NIH), Bethesda, Maryland, USA in 1985.[6] In 1989, he joined the European Molecular Biology Laboratory in Heidelberg as an independent group leader.[7] At the age of 30, he obtained the Habilitation from the Ruprecht-Karls University in Heidelberg.[4] He served as Dean of the EMBL International Ph.D. Programme from 1996 until 2005, when he became Associate Director of the EMBL and Professor for Molecular Medicine at the University of Heidelberg.[4] Together with Prof. Andreas Kulozik of the Medical Faculty of Heidelberg University, Hentze co-founded the Molecular Medicine Partnership Unit (MMPU) in 2002 and serves as its Co-Director.[8] [9] He is also co-founder of Anadys Pharmaceuticals, San Diego, California.[10]

Since 2013, Matthias Hentze is the Director of EMBL, advising and supporting EMBL's Director General, Prof. Iain Mattaj.[1]

He is married to the German physician Sabine Hentze and has three daughters. He regularly participates in city marathons of the World Marathon Majors series (New York, Boston, Chicago, London, Berlin) and is a qualified member of the Berlin Marathon Jubilee Club.[11]

Research

In 1987, Hentze and his colleagues discovered iron-responsive elements that regulate mammalian mRNA.[12] He has also studied the relationship between iron metabolism and disease and diseases of RNA metabolism, especially those relating to the Nonsense-mediated decay pathway and RNA 3’end formation. Since around 2010 Hentze has studied RNA-binding enzymes that connect cellular metabolism and gene expression.[13]

Honors and Awards (Selection)

Editorial Boards

  • Faculty of 1000, Biology and Medicine (since 2010) [21]
  • International Advisory Board, Wiley Interdisciplinary Reviews RNA (since 2009) [22]
  • Senior Editor, EMBO Molecular Medicine (since 2008) [23]
  • Molecular Cell (since 2004) [24]
  • J. Molecular Medicine (since 2004) [25]
  • BioMed Central Molecular Biology (since 2003) [26]
  • RNA (since 1997) [27]
  • Trends in Biochemical Sciences [TiBS] (since 1996) [28]


The section "Selected Publications" can remain unchanged.

Please add the following to the section "External links" below to what is already there:

At Heidelberg University Hospital

References

References

  1. ^ a b EMBL Leadership
  2. ^ Faculty at Heidelberg University Hospital
  3. ^ Matthias Hentze/Archive 1 in the German National Library catalogue
  4. ^ a b c d Leopoldina CV
  5. ^ a b DFG German Research Foundation
  6. ^ TiBS Vol. 37, No. 12
  7. ^ AARS 2015 - Keynote Speakers
  8. ^ MMPU at Heidelberg University Hospital
  9. ^ Nature: Language lessons. May 2003
  10. ^ Nasdaq.com. Registration statement of Anadys Pharmaceuticals, Inc.
  11. ^ Homepage Jubilee Club
  12. ^ Journal of Molecular Biology (1997) 274
  13. ^ Life Scientist: Enzymes with alter egos. Feb. 2014
  14. ^ 66th Mosbacher Kolloquium 2015
  15. ^ Biospektrum.de
  16. ^ Lautenschläger-Research Prize 2007 for Prof. Dr. Matthias Hentze and Prof. Dr. Andreas Kulozik
  17. ^ Biotechnology and Life Sciences in Baden-Württemberg
  18. ^ EURASC Membership Directory
  19. ^ Gottfried Wilhelm Leibniz Programme 2000
  20. ^ EMBO Membership Directory
  21. ^ F1000 Prime Faculty Members
  22. ^ Wiley Online Library
  23. ^ EMBO Press Release
  24. ^ Cell Editorial Board
  25. ^ Journal of Molecular Medicine Editorial Board
  26. ^ BMC Molecular Biology Editorial Board
  27. ^ RNA Editorial Board
  28. ^ TiBS Editorial Board

I'd appreciate it if these changes could be implemented. Thanks a lot for your comments and feedback. Princessella123 (talk) 14:56, 15 June 2015 (UTC)

Thanks for using the edit request function. I went through and fixed up the formatting. I don't have time to review now, but will try to get to it tonight. You could help by formatting the references better. Please have a look at Help:Referencing for beginners and Wikipedia:Citing_sources and consider taking some time to format them better. With regard to sourcing, please keep in mind that we value independent sources where other people write about him. What we call "self-published sources (please see WP:SPS and WP:BLPSPS) are really not what we want. Thanks. Jytdog (talk) 15:04, 15 June 2015 (UTC)
Dear Jytdog, Thanks for your comment. I've fixed the references; changed some and added additional ones. I appreciate your help with this. Thanks Princessella123 (talk) 14:11, 23 June 2015 (UTC)
I hope it's ok that I edited this talk page (i.e. the references) instead of creating a new section. Princessella123 (talk) 14:19, 23 June 2015 (UTC)

Request edit on 21 July 2015

Dear all, In response to the latest comment on my talk page I'm sending another updated request edit. I have again updated the references and also removed unnecessary bits. I'd appreciate a review of the article as well as feedback on my talk page if there are further improvements I need to make before the edit can be implemented. I'd also like to add an infobox and a photograph (copyright holder consent form has been sent on June 26th but we haven't heard back yet - could anyone perhaps help?) but I meant to wait for your feedback on the article first. Many thanks for your help with this. Princessella123 (talk) 13:19, 21 July 2015 (UTC)


Matthias Werner Hentze, MD (born 25 January 1960 in Wiedenbrück, West Germany) is a German scientist. Currently, he is the Director of the European Molecular Biology Laboratory (EMBL)[1] and Professor of Molecular Medicine at Heidelberg University.[2]

Biography

Matthias Hentze studied medicine in the UK at the Medical Schools in Southampton, Oxford, Glasgow and Cambridge, and in Germany at the Westfälische Wilhelms-Universität Münster from which he qualified in 1984. In the same year, he received his M.D. degree for work on lysosomal enzyme biogenesis in the laboratory of Prof. Kurt von Figura.[3][4][5]

After a short phase of clinical work and supported by a fellowship awarded by the Deutsche Forschungsgemeinschaft (German Research Council),[6] Hentze became a postdoctoral fellow in Dr. Richard Klausner’s laboratory at the National Institutes of Health (NIH), Bethesda, Maryland, USA in 1985.[7] In 1989, he joined the European Molecular Biology Laboratory in Heidelberg as an independent group leader.[8] At the age of 30, he obtained the Habilitation from the Ruprecht-Karls University in Heidelberg.[4] He served as Dean of the EMBL International Ph.D. Programme from 1996 until 2005, when he became Associate Director of the EMBL and Professor for Molecular Medicine at the University of Heidelberg.[4] Together with Prof. Andreas Kulozik of the Medical Faculty of Heidelberg University, Hentze co-founded the Molecular Medicine Partnership Unit (MMPU) in 2002 and serves as its Co-Director.[9] [10] He is also co-founder of Anadys Pharmaceuticals, San Diego, California.[11]

Since 2013, Matthias Hentze is the Director of EMBL, advising and supporting EMBL's Director General, Prof. Iain Mattaj.[1]

He regularly participates in city marathons of the World Marathon Majors series (New York, Boston, Chicago, London, Berlin) and is a qualified member of the Berlin Marathon Jubilee Club.[12]

Research

In 1987, Hentze and his colleagues discovered iron-responsive elements that regulate mammalian mRNA.[13] He has also studied the relationship between iron metabolism and disease and diseases of RNA metabolism, especially those relating to the Nonsense-mediated decay pathway and RNA 3′-end formation. Since around 2010 Hentze has studied RNA-binding enzymes that connect cellular metabolism and gene expression.[14]

Honors and Awards (Selection)

Editorial Boards

  • Faculty of 1000, Biology and Medicine (since 2010) [22]
  • International Advisory Board, Wiley Interdisciplinary Reviews RNA (since 2009) [23]
  • Senior Editor, EMBO Molecular Medicine (since 2008) [24]
  • Molecular Cell (since 2004) [25]
  • J. Molecular Medicine (since 2004) [26]
  • BioMed Central Molecular Biology (since 2003) [27]
  • RNA (since 1997) [28]
  • Trends in Biochemical Sciences [TiBS] (since 1996) [29]

References

  1. ^ a b EMBL Leadership. Retrieved 2015-06-12.
  2. ^ Faculty at Heidelberg University Hospital. Retrieved 2015-06-12.
  3. ^ German National Library. Retrieved 2015-07-20.
  4. ^ a b c d Leopoldina CV. Retrieved 2015-06-12.
  5. ^ Hentze, M., A. Hasilik and K. von Figura. Enhanced degradation of Cathepsin D synthesized in the presence of the threonine analog beta-hydroxynorvaline. Arch. Biochem. Biophys 230, 375-382, 1984.
  6. ^ a b DFG German Research Foundation. Retrieved 2015-06-12.
  7. ^ TiBS Vol. 37, No. 12. Retrieved 2015-06-12.
  8. ^ AARS 2015 - Keynote Speakers. Retrieved 2015-06-12.
  9. ^ MMPU at Heidelberg University Hospital. Retrieved 2015-06-12.
  10. ^ Nature: Language lessons. May 2003. Retrieved 2015-06-12.
  11. ^ Nasdaq.com. Registration statement of Anadys Pharmaceuticals, Inc. Retrieved 2015-06-12.
  12. ^ Homepage Jubilee Club. Retrieved 2015-06-12.
  13. ^ Journal of Molecular Biology (1997) 274. Retrieved 2015-06-12.
  14. ^ Life Scientist: Enzymes with alter egos. Feb. 2014. Retrieved 2015-06-12.
  15. ^ 66th Mosbacher Kolloquium 2015. Retrieved 2015-06-12.
  16. ^ Biospektrum.de. Retrieved 2015-07-20.
  17. ^ Lautenschläger-Research Prize 2007 for Prof. Dr. Matthias Hentze and Prof. Dr. Andreas Kulozik. Retrieved 2015-06-12.
  18. ^ Biotechnology and Life Sciences in Baden-Württemberg. Retrieved 2015-07-20.
  19. ^ EURASC Membership Directory. Retrieved 2015-07-20.
  20. ^ Gottfried Wilhelm Leibniz Programme 2000. Retrieved 2015-07-20.
  21. ^ EMBO Membership Directory. Retrieved 2015-07-20.
  22. ^ F1000 Prime Faculty Members. Retrieved 2015-07-20.
  23. ^ Wiley Online Library. Retrieved 2015-07-20.
  24. ^ EMBO Press - Editors & Advisory Editorial Board. Retrieved 2015-07-20.
  25. ^ Cell Editorial Board. Retrieved 2015-07-20.
  26. ^ Journal of Molecular Medicine Editorial Board. Retrieved 2015-07-20.
  27. ^ BMC Molecular Biology Editorial Board. Retrieved 2015-07-20.
  28. ^ RNA Editorial Board. Date retr. 07-20-2015
  29. ^ TiBS Editorial Board. Retrieved 2015-07-20.

Request edit on 5 August 2015 - Additions to request edit on 21 July

@The Average Wikipedian: Thanks for your helpful comments! I've now added an infobox and also updated the links of the medical schools (please see below). Yes, in fact these medical schools are part of the respective universities. Could you arrange for the edits to be "approved and implemented"? Thanks a lot for your support. Princessella123 (talk) 13:41, 5 August 2015 (UTC)

Prof. Dr. Matthias Hentze
Born (1960-01-25) January 25, 1960 (age 64)
Wiedenbrueck, Germany
NationalityGermany
CitizenshipGerman
Alma materWestfaelische Wilhelms University Muenster
Scientific career
FieldsMolecular Biology, RNA-binding proteins
Institutions
  • NIH (Bethesda, MD, USA)
  • EMBL (Heidelberg, Germany)
Thesis "Influence of amino acid analogs on maturation, transport and stability of cathepsin D in human skin fibroblasts”  (1984)


Biography

Matthias Hentze studied medicine in the UK at the Medical Schools in Southampton[1], Oxford,[2] Glasgow[3] and Cambridge,[4] and in Germany at the Westfälische Wilhelms-Universität[5] Münster from which he qualified in 1984.

References

  1. ^ Southampton Medical School. Date retr. 08-05-2015
  2. ^ Oxford Medical School. Date retr. 08-05-2015
  3. ^ Glasgow Medical School. Date retr. 08-05-2015
  4. ^ Cambridge School of Clinical Medicine. Date retr. 08-05-2015
  5. ^ Westfälische Wilhelms-Universität Münster. Date retr. 08-05-2015

Request edit on 6 August 2015 (final version)

Prof. Dr. Matthias Hentze
Born (1960-01-25) January 25, 1960 (age 64)
Wiedenbrück, Germany[3]
NationalityGerman
CitizenshipGerman
Alma materWestfälische Wilhelms-Universität Münster
Scientific career
FieldsMolecular Biology, RNA-binding proteins
Institutions
Thesis "Influence of amino acid analogs on maturation, transport and stability of cathepsin D in human skin fibroblasts”  (1984)
Websitewww.embl.de


Matthias Werner Hentze, MD (born 25 January 1960 in Wiedenbrück, West Germany) is a German scientist. Currently, he is the Director of the European Molecular Biology Laboratory (EMBL)[4] and Professor of Molecular Medicine at Heidelberg University.[5]


Biography

Matthias Hentze studied medicine in the UK at the Medical Schools at the University of Southampton[6], University of Oxford,[7] University of Glasgow[8] and University of Cambridge,[9] and in Germany at the Westfälische Wilhelms-Universität,[10] Münster from which he qualified in 1984. In the same year, he received his M.D. degree for work on lysosomal enzyme biogenesis in the laboratory of Prof. Kurt von Figura.[11][3][12]

After a short phase of clinical work and supported by a fellowship awarded by the Deutsche Forschungsgemeinschaft (German Research Council),[13] Hentze became a postdoctoral fellow in Dr. Richard Klausner’s laboratory at the National Institutes of Health (NIH), Bethesda, Maryland, USA in 1985.[14] In 1989, he joined the European Molecular Biology Laboratory in Heidelberg as an independent group leader.[15] At the age of 30, he obtained the Habilitation from the Ruprecht-Karls University in Heidelberg.[3] He served as Dean of the EMBL International Ph.D. Programme from 1996 until 2005, when he became Associate Director of the EMBL and Professor for Molecular Medicine at the University of Heidelberg.[3] Together with Prof. Andreas Kulozik of the Medical Faculty of Heidelberg University, Hentze co-founded the Molecular Medicine Partnership Unit (MMPU) in 2002 and serves as its Co-Director.[16] [17] He is also co-founder of Anadys Pharmaceuticals, San Diego, California.[18]

Since 2013, Matthias Hentze is the Director of EMBL, advising and supporting EMBL's Director General, Prof. Iain Mattaj.[4]

He regularly participates in city marathons of the World Marathon Majors series (New York, Boston, Chicago, London, Berlin) and is a qualified member of the Berlin Marathon Jubilee Club.[19]

Research

In 1987, Hentze and his colleagues discovered iron-responsive elements that regulate mammalian mRNA.[20] He has also studied the relationship between iron metabolism and disease and diseases of RNA metabolism, especially those relating to the Nonsense-mediated decay pathway and RNA 3′-end formation. Since around 2010 Hentze has studied RNA-binding enzymes that connect cellular metabolism and gene expression.[21] This research project, which focuses on REM Networks was awarded an ERC Advanced Grant of the European Research Council in 2011[22] and has meanwhile discovered hundreds of new RNA-binding proteins in the stem cells of mammals and yeast, including 50 metabolic enzymes.[23][24]

Honors and Awards (Selection)

Editorial Boards

  • Faculty of 1000, Biology and Medicine (since 2010) [33]
  • International Advisory Board, Wiley Interdisciplinary Reviews RNA (since 2009) [34]
  • Senior Editor, EMBO Molecular Medicine (since 2008) [35]
  • Molecular Cell (since 2004) [36]
  • J. Molecular Medicine (since 2004) [37]
  • BioMed Central Molecular Biology (since 2003) [38]
  • RNA (since 1997) [39]
  • Trends in Biochemical Sciences [TiBS] (since 1996) [40]

References

  1. ^ National Institutes of Health Retrieved 2015-08-06.
  2. ^ EMBL Homepage Retrieved 2015-08-06.
  3. ^ a b c d e Leopoldina CV. Retrieved 2015-06-12.
  4. ^ a b EMBL Leadership. Retrieved 2015-06-12.
  5. ^ Faculty at Heidelberg University Hospital. Retrieved 2015-06-12.
  6. ^ Southampton Medical School. Retrieved 2015-08-05.
  7. ^ Oxford Medical School. Retrieved 2015-08-05.
  8. ^ Glasgow Medical School. Retrieved 2015-08-05.
  9. ^ Cambridge School of Clinical Medicine. Retrieved 2015-08-05.
  10. ^ Westfälische Wilhelms-Universität Münster. Retrieved 2015-08-05.
  11. ^ German National Library. Retrieved 2015-07-20.
  12. ^ Hentze, M.; Hasilik, A.; Figura, Kurt v. "Enhanced degradation of Cathepsin D synthesized in the presence of the threonine analog beta-hydroxynorvaline". Arch. Biochem. Biophys. 230 (1): 375–82. PMID 6424571. Retrieved 2015-08-06.
  13. ^ a b DFG German Research Foundation. Retrieved 2015-06-12.
  14. ^ TiBS Vol. 37, No. 12. Retrieved 2015-06-12.
  15. ^ AARS 2015 - Keynote Speakers. Retrieved 2015-06-12.
  16. ^ MMPU at Heidelberg University Hospital. Retrieved 2015-06-12.
  17. ^ Nature: Language lessons. May 2003. Retrieved 2015-06-12.
  18. ^ Nasdaq.com. Registration statement of Anadys Pharmaceuticals, Inc. Retrieved 2015-06-12.
  19. ^ Homepage Jubilee Club. Retrieved 2015-06-12.
  20. ^ Journal of Molecular Biology (1997) 274. Retrieved 2015-06-12.
  21. ^ Life Scientist: Enzymes with alter egos. Feb. 2014. Retrieved 2015-06-12.
  22. ^ ERC Website. REM Networks. Retrieved 2015-08-06
  23. ^ Castello, Alfredo; Fischer, Bernd; Eichelbaum, Katrin; et al. "Insights into RNA biology from an atlas of mammalian mRNA-binding proteins". Cell. 149 (6): 1393–406. doi:10.1016/j.cell.2012.04.031. PMID 22658674. {{cite journal}}: |access-date= requires |url= (help); Explicit use of et al. in: |first3= (help) Retrieved 2015-08-06.
  24. ^ Kwon, S Chul; et al. "The RNA-binding protein repertoire of embryonic stem cells". Nature Structural & Molecular Biology. 20 (9): 1122–30. doi:10.1038/nsmb.2638. PMID 23912277. {{cite journal}}: Explicit use of et al. in: |first= (help) Retrieved 2015-08-06.
  25. ^ 66th Mosbacher Kolloquium 2015. Retrieved 2015-06-12.
  26. ^ Biospektrum.de. Retrieved 2015-07-20.
  27. ^ Lautenschläger-Research Prize 2007 for Prof. Dr. Matthias Hentze and Prof. Dr. Andreas Kulozik. Retrieved 2015-06-12.
  28. ^ Biotechnology and Life Sciences in Baden-Württemberg. Retrieved 2015-07-20.
  29. ^ Leopoldina. Nationale Akadamie der Wissenschaften. Retrieved 2015-08-06.
  30. ^ EURASC Membership Directory. Retrieved 2015-07-20.
  31. ^ Gottfried Wilhelm Leibniz Programme 2000. Retrieved 2015-07-20.
  32. ^ EMBO Membership Directory. Retrieved 2015-07-20.
  33. ^ F1000 Prime Faculty Members. Retrieved 2015-07-20.
  34. ^ Wiley Online Library. Retrieved 2015-07-20.
  35. ^ EMBO Press - Editors & Advisory Editorial Board. Retrieved 2015-07-20.
  36. ^ Cell Editorial Board. Retrieved 2015-07-20.
  37. ^ Journal of Molecular Medicine Editorial Board. Retrieved 2015-07-20.
  38. ^ BMC Molecular Biology Editorial Board. Retrieved 2015-07-20.
  39. ^ RNA Editorial Board. Date retr. 07-20-2015
  40. ^ TiBS Editorial Board. Retrieved 2015-07-20.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Talk:Matthias_Hentze/Archive_1&oldid=1164856622"